A government-appointed panel of experts on Covid will take up the applications filed by the Serum Institute of India, Bharat Biotech and Pfizer for the emergency use approval for the coronavirus vaccines today.
Serum Institute had made presentations before the panel on Wednesday regarding the vaccine ‘Covishield’ developed by Oxford University and pharma major AstraZeneca and Bharat Biotech which has partnered the Indian Council of Medical Research (ICMR) for its ‘Covaxin’.
Once the vaccines are cleared by the expert panel, the applications will move to the Drugs Controller General of India (DCGI) for final approval.
With the objective of gearing up for the roll-out of COVID19 vaccine across the country, the Central Government has asked all States and UTs to ensure effective preparedness for the vaccine roll-out.
The dry run will be conducted by all the State and UT governments on 2nd January 2021 (Saturday). The activity is proposed to be conducted in all State Capitals in at least 3 session sites; some States will also include districts that are situated in difficult terrain/have poor logistical support; Maharashtra and Kerala are likely to schedule the dry run in major cities other than their Capital.
The objective of the Dry Run for COVID-19 vaccine introduction is to assess operational feasibility in the use of Co-WIN application in field environment, to test the linkages between planning and implementation and to identify the challenges and guideway forward prior to actual implementation. This is also expected to give confidence to programme managers at various levels.
The States/UTs have been asked to ensure that the data of these beneficiaries is uploaded in Co-WIN. These beneficiaries will also be available at the session site for the dry run. The States and UTs shall prepare the facilities and users to be created on CoWIN application including uploading the data of Health Care Worker (HCW) beneficiaries.
The States/UTs have been asked to ensure physical verification of all proposed sites for the adequacy of space, logistical arrangements, internet connectivity, electricity, safety etc; prepare at least three model session sites in each State (at State capital) for demonstration; ensure that the Model Sites have separate entry and exit in a ‘three-room set-up’ with adequate space outside for awareness generation activities; display all IEC material at these sites; ensure that all SOPs and protocols are being practiced at the identified sites in an ideal environment along with vaccination teams to be identified and trained in all aspects.
The dry run will also equip the State and UT administration in the management of vaccine supply, storage and logistics including cold chain management.